P: Cardiovascular System 3

Cardiovascular System

Overview

The cardiovascular system is responsible for the transport of blood, nutrients, gases, and wastes throughout the body. This section focuses on blood types, transfusion compatibility, and the mechanisms of hemostasis (blood clotting).

Blood Types and Transfusion

ABO Blood Group System

The ABO blood group system classifies human blood based on the presence or absence of antigens (A and B) on the surface of red blood cells (RBCs). The main blood types are A, B, AB, and O.

• Antigens: Molecules found on the surface of RBCs that determine blood type.

• Antibodies: Proteins in plasma that react against specific antigens not present on the individual's own RBCs.

• Blood Types:

  • Type A: Has A antigen on RBCs, anti-B antibodies in plasma.

  • Type B: Has B antigen on RBCs, anti-A antibodies in plasma.

  • Type AB: Has both A and B antigens, no anti-A or anti-B antibodies (universal recipient).

  • Type O: Has no A or B antigens, both anti-A and anti-B antibodies (universal donor).

Blood Group	Antigen on RBC	Antibody in Plasma	Can Donate To	Can Receive From
A	A	Anti-B	A, AB	A, O
B	B	Anti-A	B, AB	B, O
AB	A and B	None	AB	A, B, AB, O
O	None	Anti-A, Anti-B	A, B, AB, O	O

Rh Factor

The Rh factor is another antigen (D antigen) present (+) or absent (−) on RBCs. It is important in transfusion and pregnancy.

• Rh+ (positive): Has the D antigen.

• Rh− (negative): Lacks the D antigen.

• Anti-Rh antibodies are not naturally present; they develop after exposure to Rh+ blood.

Transfusion Rules:

• Rh+ individuals can receive Rh+ or Rh− blood.

• Rh− individuals should only receive Rh− blood to prevent sensitization.

Hemolytic Disease of the Newborn (Erythroblastosis Fetalis): Occurs when an Rh− mother carries an Rh+ fetus, leading to maternal antibody production against fetal RBCs in subsequent pregnancies.

Evolutionary Perspective on Blood Types

Blood type diversity is maintained by selective pressure from infectious diseases.

• Type O blood is less susceptible to Plasmodium falciparum (malaria) because the parasite does not bind well to type O RBCs.

• Type O individuals are more prone to severe illness from cholera.

• Other blood types may confer susceptibility or resistance to different infections.

Hemostasis and Blood Clotting

Hemostasis Overview

Hemostasis is the process that stops bleeding at the site of an injury. It involves vascular spasm, platelet plug formation, and coagulation (clotting).

Platelet Plug Formation

• Endothelial cells secrete prostacyclin and nitric oxide (NO) to inhibit platelet aggregation under normal conditions.

• The enzyme CD39 on endothelial cells breaks down ADP to AMP and Pi, further inhibiting platelet aggregation.

• When a vessel is injured, platelets adhere to exposed collagen fibers and secrete substances (e.g., thromboxane A2) that promote vasoconstriction and platelet aggregation.

• Von Willebrand factor (VWF): Mediates platelet adhesion to the site of injury.

Coagulation Cascade

The coagulation cascade is a series of enzymatic reactions that culminate in the conversion of fibrinogen (soluble) to fibrin (insoluble), forming a stable blood clot.

• Coagulation factors are mostly proteolytic enzymes (serine proteases) and are numbered (e.g., Factor I, II, etc.).

• Deficiency of certain factors leads to coagulopathies (bleeding disorders).

• Clotting is regulated to prevent excessive clot formation.

Equation for Fibrin Formation:

$\text{Fibrinogen} \xrightarrow{\text{Thrombin}} \text{Fibrin}$

Clot Dissolution (Fibrinolysis)

• After vessel repair, the enzyme plasmin breaks down fibrin, dissolving the clot.

• Anticoagulants inactivate clotting factors after their job is done, and the liver clears them from circulation.

Clinical Problems and Applications

Blood Transfusion Compatibility

• Type O is the universal donor; type AB is the universal recipient.

• Transfusion reactions can occur if incompatible blood is given, leading to hemolysis.

Red Blood Cell Disorders

• Microcytic, hypochromic anemia: Characterized by small, pale RBCs with reduced hemoglobin content, leading to decreased oxygen delivery to tissues.

Coagulation Disorders

• Deficiency or dysfunction of clotting factors impairs hemostasis and increases bleeding risk.

• Excessive clotting can lead to thrombosis.

Sample Table: ABO and Rh Blood Group Compatibility

Recipient	Can Receive From
O−	O−
O+	O−, O+
A−	O−, A−
A+	O−, O+, A−, A+
B−	O−, B−
B+	O−, O+, B−, B+
AB−	O−, A−, B−, AB−
AB+	All types (universal recipient)

Key Terms

• Antigen: A molecule capable of inducing an immune response.

• Antibody: A protein produced by B lymphocytes that binds to a specific antigen.

• Hemostasis: The process of stopping bleeding.

• Fibrinolysis: The enzymatic breakdown of the fibrin in blood clots.

• Coagulopathy: A condition in which the blood’s ability to clot is impaired.

Additional info: Some explanations and tables have been expanded for academic completeness and clarity.